RAPAMYCIN ESTERS Russian patent published in 2000 - IPC

Abstract RU 2160739 C2

FIELD: medicine. SUBSTANCE: described are new rapamycin esters of general formula I: wherein R1 is ; R2 is hydrogen or is as defined above for R1, and n is 8-200. Compounds are useful as immunosuppressive antiinflammatory, antifungal, antiproliferative and antitumor agent. EFFECT: improved properties of the title compound. 7 cl, 5 ex

Similar patents RU2160739C2

Title Year Author Number
C-22 STABILIZED DERIVATIVES OF RAPAMYCIN, METHOD OF IMMUNO- -SUPPRESSION INDUCING, METHOD OF TREATMENT AND PROPHYLAXIS OF TRANSPLANT REJECTION OR HOMOLOGOUS DISEASE, METHOD OF TREATMENT OR PROPHYLAXIS OF HYPERPROLIFERATIVE VASCULAR DISORDER 1994
  • Nelson Frehnsis Kristi
RU2152946C1
RAPAMYCIN 42-OXIMES AND HYDROXYLAMINES, METHOD OF SYNTHESIS, INTERMEDIATE COMPOUNDS, PHARMACEUTICAL COMPOSITION AND METHOD OF TREATMENT OF PATIENT 1995
  • Amedeo Arturo Failli
  • Gaj Alan Shikhser
  • Oleg Igorevich Blejman
RU2172316C2
RAPAMYCIN HYDROXYESTERS, METHOD OF THEIR SYNTHESIS AND METHODS OF TREATMENT 1995
  • Dzheral'D Stenli Skotnitski
  • Kristina Luiza Leon
  • Gaj Alan Shizer
RU2134267C1
RAPAMYCIN DERIVATIVES, A PHARMACEUTICAL COMPOSITION AND A METHOD OF IMMUNODEPRESSION STIMULATING 1993
  • Venling Kao
  • Magid A.Abou-Gkharbia
  • Robert L.Vogel
RU2126409C1
RAPAMYCIN PREPARATIONS FOR ORAL USING 1998
  • Nadzhi Arvinder Singkh
RU2184541C2
AMINOMETHYL-2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-E]-INDOLE-8-ONE COMPOUNDS AND METHOD OF TREATMENT 1996
  • Stehk Gehri Pol
  • M'Jusho Richard Ehrik
  • Bravo Bajron Abel'
  • Kang Jang Khi
RU2178416C2
TRIS-CARBAMIC ACID ESTERS, METHOD OF CHOLESTEROL ABSORPTION DECREASE, PHARMACEUTICAL COMPOSITION FOR CHOLESTEROL ABSORPTION DECREASE 1994
  • Tomas Dzhozef Kommons
  • Donal'D Piter Strajk
  • Krista Mari Ljakler
RU2130928C1
DERIVATIVES OF [([2- (AMINO -3,4-DIOXO -1-CYCLOBUTENE -1-YL)AMINO]ALKYL)] ACIDS 1992
  • Uil'Jam Alvin Kinni[Us]
  • Dinna Kolett Garrison[Us]
RU2039035C1
DERIVATIVES OF SPIRO-[ISOQUINOLINE-4-(1H)-3-PYRROLIDINE]-1,2',3,5'-(2H)-TETR- -ONE, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION USED FOR PREVENTION OR TREATMENT OF DIABETES MELLITUS-RELATED COMPLICATIONS 1991
  • Majkl Sotirios Malamas[Gr]
RU2110518C1
SUBSTITUTED PYRIMIDINES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, OR N-OXIDES, METHODS OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF 1992
  • Dzhon Vatson Ehllingboj
  • Madelen Nikajdo
  • Zhak Framros Bazhli
RU2113437C1

RU 2 160 739 C2

Authors

Khjuk-Koo Li

Tianmin Zhu

Dates

2000-12-20Published

1996-12-25Filed